Abstract:Deacetylcephalosporin C synthase (DACS), a 2-oxoglutarate-dependent oxygenase synthesized by Streptomyces clavuligerus, transforms an inert methyl group of deacetoxycephalosporin C (DAOC) into an active hydroxyl group of deacetylcephalosporin C (DAC) during the biosynthesis of cephalosporin. It is a step which is chemically difficult to accomplish, but its development by use of an enzymatic method with DACS can facilitate a cost-effective technology for the manufacture of semisynthetic cephalosporin intermediates such as 7-amino-cephalosporanic acid (7ACA) and hydroxymethyl-7-amino-cephalosporanic acid (HACA) from cephalosporin G. As the native enzyme showed negligible activity toward cephalosporin G, an unnatural and less expensive substrate analogue, directed-evolution strategies such as random, semirational, rational, and computational methods were used for systematic engineering of DACS for improved activity. In comparison to the native enzyme, several variants with improved catalytic efficiency were found. The enzyme was stable for several days and is expressed in soluble form at high levels with significantly higher kcat/Km values. The efficacy and industrial scalability of one of the selected variants, CefFGOS, were demonstrated in a process showing complete bioconversion of 18 g/liter of cephalosporin G into deacetylcephalosporin G (DAG) in about 80 min and showed reproducible results at higher substrate concentrations as well. DAG could be converted completely into HACA in about 30 min by a subsequent reaction, thus facilitating scalability toward commercialization. The experimental findings with several mutants were also used to rationalize the functional conformation deduced from homology modeling, and this led to the disclosure of critical regions involved in the catalysis of DACS. Importance: 7ACA and HACA serve as core intermediates for the manufacture of several semisynthetic cephalosporins. As they are expensive, a cost-effective enzyme technology for the manufacture of these intermediates is required. Deacetylcephalosporin C synthase (DACS) was identified as a candidate enzyme for the development of technology from cephalosporin G in this study. Directed-evolution strategies were employed to enhance the catalytic efficiency of deacetylcephalosporin C synthase. One of the selected mutants of deacetylcephalosporin C synthase could convert high concentrations of cephalosporin G into DAG, which subsequently could be converted into HACA completely. As cephalosporin G is inexpensive and readily available, the technology would lead to a substantial reduction in the cost for these intermediates upon commercialization.

Deacetoxycephalosporin C synthase (expandase): Research progress and application potential

Mechanistic Insights into the Oxidative Ring Expansion from Penicillin N to Deacetoxycephalosporin C Catalyzed by a Nonheme Iron(II) and Α-Kg-dependent Oxygenase.

Modified Deacetylcephalosporin C Synthase for the Biotransformation of Semisynthetic Cephalosporins

Whole-Cell Biotransformation of Penicillin G by a Three-Enzyme Co-expression System with Engineered Deacetoxycephalosporin C Synthase

Characterization and engineering of cephalosporin C acylases to produce 7-Aminocephalosporanic acid

Research Progress in One-Step Enzymatic Conversion of Cephalosporin C to 7-Aminocephalosporanic Acid

A novel cephalosporin deacetylating acetyl xylan esterase from Bacillus subtilis with high activity toward cephalosporin C and 7-aminocephalosporanic acid

Biosynthetic Study of Cephalosporin P1 Reveals a Multifunctional P450 Enzyme and a Site-Selective Acetyltransferase.

Cephalosporin C biosynthesis and fermentation in Acremonium chrysogenum

Cephalosporins as key lead generation beta-lactam antibiotics

Effect on Cephalosporin C Production after Overexpressing cefM in Acremonium chrysogenum

Directed Evolution of Cephalosporin C Acylase Activity by Error-prone PCR

Research progress on cephalosporin acylase for 7-ACA preparation

High-level Expression of Cephalosporin C Deacetylase from Bacillus Subtilis SIL3 in Escherichia Coli by a Multilevel Collaborative Strategy

Progress in enzymatic conversion of cephalosporin C to 7-aminocephalosporanic acid

Computational design of new enzymes for hydrolysis and synthesis of third-generation cephalosporin antibiotics

Enhanced Enzymatic Synthesis of a Cephalosporin, Cefadroclor, in the Presence of Organic Co-solvents

Improvement of Cephalosporin C Production by Recombinant DNA Integration in Acremonium Chrysogenum

One-pot enzymatic production of deacetyl-7-aminocephalosporanic acid from cephalosporin C via immobilized cephalosporin C acylase and deacetylase

Penicillin Acylase-Catalyzed Synthesis of N-bromoacetyl-7-aminocephalosporanic Acid, the Key Intermediate for the Production of Cefathiamidine

Construction of Recombinant Escherichia Coli D11/pMSTO and Its Use in Enzymatic Preparation of 7-Aminocephalosporanic Acid in One Pot